Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | glucagon-like peptide 1 receptor | Starlite/ChEMBL | No references |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Loa Loa (eye worm) | pigment dispersing factor receptor c | glucagon-like peptide 1 receptor | 463 aa | 388 aa | 25.8 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Loa Loa (eye worm) | pigment dispersing factor receptor c | 0.006 | 0.2105 | 0.2407 |
Toxoplasma gondii | histone lysine methyltransferase SET/SUV39 | 0.0032 | 0.0949 | 0.5 |
Brugia malayi | Latrophilin receptor protein 2 | 0.0019 | 0.0423 | 0.0484 |
Entamoeba histolytica | hypothetical protein | 0.0038 | 0.1217 | 0.5 |
Loa Loa (eye worm) | TAR-binding protein | 0.0139 | 0.5325 | 0.6091 |
Loa Loa (eye worm) | hypothetical protein | 0.0019 | 0.0423 | 0.0484 |
Trichomonas vaginalis | set domain proteins, putative | 0.0253 | 1 | 0.5 |
Echinococcus granulosus | GPCR family 2 | 0.0019 | 0.0423 | 0.0794 |
Schistosoma mansoni | tar DNA-binding protein | 0.0139 | 0.5325 | 1 |
Schistosoma mansoni | hypothetical protein | 0.0019 | 0.0423 | 0.0794 |
Echinococcus multilocularis | Basic leucine zipper (bZIP) transcription | 0.0038 | 0.1217 | 0.2286 |
Echinococcus multilocularis | tar DNA binding protein | 0.0139 | 0.5325 | 1 |
Loa Loa (eye worm) | MH2 domain-containing protein | 0.0128 | 0.4864 | 0.5563 |
Echinococcus granulosus | diuretic hormone 44 receptor GPRdih2 | 0.0019 | 0.0423 | 0.0794 |
Echinococcus multilocularis | histone lysine N methyltransferase SETMAR | 0.0032 | 0.0949 | 0.1783 |
Schistosoma mansoni | tar DNA-binding protein | 0.0139 | 0.5325 | 1 |
Entamoeba histolytica | hypothetical protein | 0.0038 | 0.1217 | 0.5 |
Loa Loa (eye worm) | latrophilin receptor protein 2 | 0.0019 | 0.0423 | 0.0484 |
Schistosoma mansoni | histone-lysine n-methyltransferase suv9 | 0.0032 | 0.0949 | 0.1783 |
Brugia malayi | RNA recognition motif domain containing protein | 0.0139 | 0.5325 | 0.6091 |
Entamoeba histolytica | hypothetical protein | 0.0038 | 0.1217 | 0.5 |
Echinococcus granulosus | histone lysine methyltransferase setb | 0.0032 | 0.0949 | 0.1783 |
Schistosoma mansoni | transcription factor LCR-F1 | 0.0038 | 0.1217 | 0.2286 |
Echinococcus multilocularis | cadherin EGF LAG seven pass G type receptor | 0.0019 | 0.0423 | 0.0794 |
Brugia malayi | hypothetical protein | 0.0038 | 0.1217 | 0.1392 |
Loa Loa (eye worm) | hypothetical protein | 0.0032 | 0.0949 | 0.1086 |
Schistosoma mansoni | hypothetical protein | 0.0019 | 0.0423 | 0.0794 |
Echinococcus granulosus | cadherin EGF LAG seven pass G type receptor | 0.0019 | 0.0423 | 0.0794 |
Loa Loa (eye worm) | RNA recognition domain-containing protein domain-containing protein | 0.0139 | 0.5325 | 0.6091 |
Loa Loa (eye worm) | RNA binding protein | 0.0139 | 0.5325 | 0.6091 |
Brugia malayi | Pre-SET motif family protein | 0.0223 | 0.8743 | 1 |
Schistosoma mansoni | tar DNA-binding protein | 0.0139 | 0.5325 | 1 |
Brugia malayi | MH2 domain containing protein | 0.0128 | 0.4864 | 0.5563 |
Entamoeba histolytica | hypothetical protein | 0.0038 | 0.1217 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0041 | 0.1326 | 0.1517 |
Loa Loa (eye worm) | pre-SET domain-containing protein family protein | 0.0223 | 0.8743 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.006 | 0.2105 | 0.2407 |
Schistosoma mansoni | hypothetical protein | 0.0038 | 0.1217 | 0.2286 |
Schistosoma mansoni | histone-lysine n-methyltransferase setb1 | 0.0032 | 0.0949 | 0.1783 |
Schistosoma mansoni | histone-lysine n-methyltransferase setb1 | 0.0032 | 0.0949 | 0.1783 |
Echinococcus multilocularis | histone lysine methyltransferase setb histone lysine methyltransferase eggless | 0.0032 | 0.0949 | 0.1783 |
Schistosoma mansoni | tar DNA-binding protein | 0.0139 | 0.5325 | 1 |
Echinococcus multilocularis | GPCR, family 2 | 0.0019 | 0.0423 | 0.0794 |
Brugia malayi | TAR-binding protein | 0.0139 | 0.5325 | 0.6091 |
Echinococcus granulosus | 5'partial|histone lysine N methyltransferase SETDB2 | 0.0031 | 0.0901 | 0.1693 |
Echinococcus granulosus | Basic leucine zipper bZIP transcription | 0.0038 | 0.1217 | 0.2286 |
Brugia malayi | Corticotropin releasing factor receptor 2 precursor, putative | 0.006 | 0.2105 | 0.2407 |
Echinococcus multilocularis | diuretic hormone 44 receptor GPRdih2 | 0.0019 | 0.0423 | 0.0794 |
Schistosoma mansoni | hypothetical protein | 0.0019 | 0.0423 | 0.0794 |
Brugia malayi | Calcitonin receptor-like protein seb-1 | 0.006 | 0.2105 | 0.2407 |
Brugia malayi | calcium-independent alpha-latrotoxin receptor 2, putative | 0.0019 | 0.0423 | 0.0484 |
Schistosoma mansoni | histone-lysine n-methyltransferase setb1 | 0.0032 | 0.0949 | 0.1783 |
Loa Loa (eye worm) | transcription factor SMAD2 | 0.0128 | 0.4864 | 0.5563 |
Schistosoma mansoni | hypothetical protein | 0.0041 | 0.1326 | 0.249 |
Plasmodium vivax | SET domain protein, putative | 0.0032 | 0.0949 | 0.5 |
Brugia malayi | RNA binding protein | 0.0139 | 0.5325 | 0.6091 |
Schistosoma mansoni | hypothetical protein | 0.0019 | 0.0423 | 0.0794 |
Echinococcus granulosus | tar DNA binding protein | 0.0139 | 0.5325 | 1 |
Brugia malayi | latrophilin 2 splice variant baaae | 0.0041 | 0.1326 | 0.1517 |
Brugia malayi | Pre-SET motif family protein | 0.0032 | 0.0949 | 0.1086 |
Schistosoma mansoni | tar DNA-binding protein | 0.0139 | 0.5325 | 1 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
EC50 (binding) | > 300 um | PUBCHEM_BIOASSAY: Fluorescent Polarization Homogeneous Dose Response HTS to Identify Inhibitors of Mex-5 Binding to TCR-2. (Class of assay: confirmatory) [Related pubchem assays: 1833 (Project Summary), 1832 (Primary HTS)] | ChEMBL. | No reference |
EC50 (binding) | > 300 um | PUBCHEM_BIOASSAY: Fluorescent Polarization Homogeneous Dose Response HTS to Identify Inhibitors of POS-1 Binding to mex-3-RNA. (Class of assay: confirmatory) [Related pubchem assays: 1833 (Project Summary), 1832 (Primary HTS)] | ChEMBL. | No reference |
IC50 (functional) | 155.089 uM | PubChem BioAssay. Absorbance-based biochemical high throughput dose response assay to identify inhibitors of Methionine sulfoxide reductase A (MsrA). (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 13.1154 uM | PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488745, AID488752, AID488774, AID504848, AID504850] | ChEMBL. | No reference |
Potency (functional) | 14.1254 uM | PubChem BioAssay. qHTS of GLP-1 Receptor Inverse Agonists (Inhibition Mode). (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 29.081 uM | PUBCHEM_BIOASSAY: qHTS screen for small molecules that inhibit ELG1-dependent DNA repair in human embryonic kidney (HEK293T) cells expressing luciferase-tagged ELG1. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493107, AID493125] | ChEMBL. | No reference |
Potency (functional) | 35.4813 uM | PUBCHEM_BIOASSAY: qHTS for Inhibitors of TGF-b: Cytotox Counterscreen. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588855, AID588860] | ChEMBL. | No reference |
Potency (functional) | 37.933 uM | PUBCHEM_BIOASSAY: qHTS profiling assay for firefly luciferase inhibitor/activator using purified enzyme and Km concentrations of substrates (counterscreen for miR-21 project). (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2288, AID2289, AID2598, AID411] | ChEMBL. | No reference |
Potency (functional) | 100 uM | PUBCHEM_BIOASSAY: HTS for Inhibitors of HP1-beta Chromodomain Interactions with Methylated Histone Tails. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488962] | ChEMBL. | No reference |
Species name | Source | Reference | Is orphan |
---|---|---|---|
Plasmodium falciparum | ChEMBL23 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.